Στανίτσα Ευαγγελία

Academic research and publications

• 1. Angelopoulou E., Stanitsa E., Karpodini C.C., Bougea A., Kontaxopoulou D., Fragkiadaki S., Koros C., Georgakopoulou V.E., Fotakopoulos G., Koutedakis Y., Piperi C., Papageorgiou S. Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson’s Disease: An Updated Review. Medicina. 2023; 59(8):1454. https://doi.org/10.3390/medicina59081454
• 2. Koros, C., Simitsi, A. M., Bougea, A., Papagiannakis, N., Antonelou, R., Pachi, I., Angelopoulou, E., Prentakis, A., Zachou, A., Chrysovitsanou, C., Beratis, I., Fragkiadaki, S., Kontaxopoulou, D., Efthymiopoulou, E., Stanitsa, E., Potagas, C., Papageorgiou, S. G., Karavasilis, E., Velonakis, G., Prassopoulos, V., Geronikola-Trapali, X. & Stefanis, L. (2023). Double Trouble: Association of Malignant Melanoma with Sporadic and Genetic Forms of Parkinson’s Disease and Asymptomatic Carriers of Related Genes: A Brief Report. Medicina, 59(8), 1360.
• 3. Koros, C, Simitsi, A.M., Papagiannakis, Ni., Bougea, A., Prentakis, A., Papadimitriou, D., Pachi, I., Beratis, I., Stanitsa, E., Angelopoulou, E., Antonelou, R., Bregianni, M., Lourentzos, K., Papageorgiou, S. G., Bonakis, A., Trapali Geronicola, X., Stamelou, M., Stefanis, L. (2023). Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson’s Disease: Longitudinal Data from the PPMI Study. Journal of Parkinson's Disease, (Preprint), 1-8. doi: 10.3233/JPD-230007
• 4. Papastefanopoulou V., Simoudis A., Charoniti E., Papadopoulou M., Stanitsa E., Papatriantafyllou, I., Papageorgiou S. and Kroupis C. (2023) Investigation of ARMS2 and CFH Polymorphisms Associated with Age-Related Macular Degeneration in Alzheimer’s Disease Patients. A Greek Cohort Study. Biomedical Journal of Scientific and Technical Research, 40986-40992.
• 5. Fragkiadaki, S., Kontaxopoulou, D., Stanitsa, E., Angelopoulou, E., Pavlou, D., Šemrov, D., ... & Papageorgiou, S. G. (2023). How Well Did the Healthcare System Respond to the Healthcare Needs of Older People with and without Dementia during the COVID-19 Pandemic? The Perception of Healthcare Providers and Older People from the SI4CARE Project in the ADRION Region. Geriatrics, 8(1), 21.
• 6. Angelopoulou, E., Stanitsa, E., Fragkiadaki, S., Kontaxopoulou, D., Pavlou, D., Papatriantafyllou, I., & Papageorgiou, S. Telemedicine in neurodegenerative diseases: Opportunities and challenges. Arch Hellen Med, 40(1), January-February 2023, 92-101.
• 7. Papastefanopoulou, V. †, Stanitsa, E. †, Koros, C., Simoudis, A., Florou-Hatziyiannidou, C., Beratis, I., Antonelou, R., Andronas, N., Voskou, P., Angelopoulou, E. Papatriantafyllou, J., Stefanis, L., Kroupis, C.‡, Papageorgiou, S. G. ‡, (2022). APOE allele frequency in Southern Greece: Exploring the role of Geographical Gradient in the Greek Population. Geriatrics, 8(1), 1.
• 8. Angelopoulou, E., Papachristou, N., Bougea, A., Stanitsa, E., Kontaxopoulou, D., Fragkiadaki, S., Pavlou, D., Koros, C., De ˘girmenci, Y., Papatriantafyllou, J., Thireos, E., Politis, A., Tsouros, A., Bamidis, P., Stefanis, L., Papageorgiou, S. (2022). How Telemedicine Can Improve the Quality of Care for Patients with Alzheimer’s Disease and Related Dementias? A Narrative Review. Medicina, 58(12), 1705.
• 9. Simitsi, A.M., Koros, C., Stamelou, M., Beratis, I., Efthymiopoulou, E., Papadimitriou, D., Bougea, A., Picillo, M., Stanitsa, E., Papagiannakis, N. and Antonelou, R., Pachi, I., Papageorgiou, S., Barone, P., Stefanis, L. (2022). Asymptomatic carriers of the p. A53T SNCA mutation: Data from the PPMI study. Parkinsonism & Related Disorders, 98, 72-74.
• 10. Dimitrakis, E., Katsarou, M. S., Lagiou, M., Papastefanopoulou, V., Stanitsa, E., Spandidos, D. A., ... & Drakoulis, N. (2022). Association of vitamin D receptor gene TaqI polymorphism with Alzheimer's disease in a Southeastern European Caucasian population. Experimental and Therapeutic Medicine, 23(5), 1-7.
• 11. Stanitsa, E., Economou, A., Beratis, I., Kontaxopoulou, D., Fragkiadaki, S., Papastefanopoulou, V., Pavlou, D., Papadoniou, P., Kroupis, C., Papatriantafyllou, J., & Stefanis, L., Yannis, G., & Papageorgiou, S. G. (2021). Effect of Apolipoprotein E4 on the Driving Behavior of Patients with Amnestic Mild Cognitive Impairment or Mild Alzheimer’s Disease Dementia. Journal of Alzheimer's disease, 84(3), 1005-1014.
• 12. Liozidou, A., Traikapi, A., Stanitsa, E., Kontaxopoulou, D., Fragkiadaki, S., Bearits, I., Nunéz Fernandez, S., Rivera, D., Kingsley, K., Arango-Lasprilla, J. (2021). Neuropsychology in Greece: Results from a survey of practicing professionals. Applied Neuropsychology: Adult, 1-12.
• 13. Charoniti, E., Papastefanopoulou, V., Hatziyannidou, C., Koros, C., Stanitsa, E., Papatriantafyllou, I., Papageorgiou, S.G., Kroupis, C. (2021). TARDBP p. I383V, a recurrent alteration in Greek FTD patients. Journal of the Neurological Sciences, 428, 117566.